Adam C. Fisher, PhD

Director of Science Staff, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, FDA

Articles

The Manufacturing Edge on Path to Market

FDA backs the benefits of adopting continuous manufacturing, a strategy which has accelerated approval and launch timelines, and its Emerging Technology Program could be a helpful tool.